retatrutide gip glp-1 glucagon receptor agonist Retatrutide Before and After: Doctor Reveals Real Results Demonstrated metabolic effects of GIP,
Description
Despite the benefits of GLP-1 RAs, they are not commonly prescribed in people living with T2DM and CKD
[DOI] [PMC free article] [PubMed] [Google Scholar] 209.Kato M., et al
All studies to date on GLP-1 medications show nutritional consequences
Baggio L, Kieffer TJ, and Drucker DJ
Moreover, GLP-1RAs have neuroprotective, anti-infectious, cardiovascular protective, and metabolic regulatory effects, exhibiting good application prospects
in 2025, the European Medicines Agency concluded that NAION is a very rare side effect of semaglutide medicines
